Effectiveness of group metacognitive therapy in self-efficacy and defense styles in women with multiple sclerosis

This study aims to investigate the effectiveness of group metacognitive therapy in self-efficacy and defense styles in women with multiple sclerosis (MS).
In this clinical trial (code: IRCT2015091624054N1), from among all the patients suffering from multiple sclerosis, who were referred to the MS Society in Khorasan Razavi in 2014, 30 women were selected through available sampling method and were randomly assigned to two groups: an experimental group and a control group. The experimental group received metacognitive therapy for eight weeks while the control group spent the routine process of the sessions held by the MS Society. For data collection, Sherer General Self-Efficacy Scale (GSE) and Defense Styles Questionnaire (DSQ) were administered in the pretest, posttest and follow-up test. Repeated-measures ANOVA with a significance level α of 0.05 were conducted for data analysis.
The results showed that group metacognitive therapy led to a significantly higher level of self-efficacy (P It seems that group metacognitive therapy can improve self-efficacy and increase the use of mature defense mechanisms in women with multiple sclerosis.